PROIOXIS VENTURES FUND LLC
PROIOXIS VENTURES FUND LLC is a Series C+, secondary, series-e and series-h fund in global and asia investing in AI, Climate, Consumer, Fintech, Healthcare, food-tech, oncology and transportation.
- Stages
- Series C+, secondary, series-e, series-h
- Sectors
- AI, Climate, Consumer, Fintech, Healthcare, food-tech, oncology, transportation
- Invests in
- global, asia
- Actively investing
- Yes
- Founded
- 2013
- Assets under management
- $1.3B
- Website
- proioxis.ventures
Check size not disclosed
Thesis
Proioxis Ventures is a venture capital firm established in 2013, headquartered in Singapore with a legal domicile in Delaware, USA. Operating as an Exempt Reporting Adviser (ERA), the firm employs a global investment strategy with a strong emphasis on the Asian market. Their investment thesis centers on technology-driven sectors including consumer tech, clean tech, climate tech, fintech, food tech, health tech, oncology, artificial intelligence, and transportation. Proioxis primarily engages in later-stage investments, frequently participating in secondary market transactions and Series C, E, and H funding rounds. While specific fund sizes and AUM are not publicly detailed, one filing indicates a Venture Capital Fund with a Gross Asset Value of $1.3 billion. The firm is actively seeking new investments.
Common questions
Does PROIOXIS VENTURES FUND LLC invest at the Series C+ stage?
Yes. PROIOXIS VENTURES FUND LLC lists Series C+, secondary, series-e and series-h among the stages it invests in.
Where does PROIOXIS VENTURES FUND LLC invest?
PROIOXIS VENTURES FUND LLC invests in global and asia.